FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016751193> ?p ?o ?g. }

• W2016751193 endingPage "e970" @default.
• W2016751193 startingPage "e966" @default.
• W2016751193 abstract "The aim of this study was to evaluate the in vitro activities of antimicrobial agents including fosfomycin tromethamine against Gram-negative isolates recovered from urine samples.A total of 2334 strains (1562 Escherichia coli, 509 Klebsiella spp, 85 Proteus spp, 75 Pseudomonas spp, 45 Enterobacter spp, 37 Acinetobacter baumannii, 8 Citrobacter spp, 7 Morganella morganii, and 6 Serratia spp) were identified by VITEK 2 during the study period, November 2008 to June 2012. Antimicrobial susceptibilities of the strains were also evaluated using the Kirby-Bauer disk diffusion method, in accordance with the Clinical and Laboratory Standards Institute guidelines.Overall, 2160 (92.5%) of the isolates tested were susceptible to fosfomycin tromethamine. Higher resistance rates were observed among inpatients compared to outpatients. Resistance rates by strain were: 2.0% for E. coli, 4.4% for Enterobacter spp, 6.9% for Klebsiella spp, 9.4% for Proteus spp, 48.6% for A. baumannii, 56.0% for Pseudomonas spp, and 100% for Morganella morganii. All Serratia spp and Citrobacter spp strains were susceptible. Extended-spectrum beta-lactamase (ESBL)-producing isolates displayed higher fosfomycin resistance rates than negative strains (19.2% vs. 2.9%). The highest in vitro activity was detected for amikacin, piperacillin-tazobactam, and imipenem for all strains including ESBL-producers.Regardless of ESBL production, the excellent activity of fosfomycin against E. coli, Enterobacter spp, Serratia spp, and Citrobacter spp, indicates that the drug is a valuable therapeutic option for urinary tract infections, even those with co-trimoxazole- and ciprofloxacin-resistant isolates, but not in ESBL-producing Klebsiella spp, Pseudomonas spp, A. baumannii, and Proteus spp. Further studies should be carried out to determine the in vivo drug activity among Enterobacteriaceae other than E. coli." @default.
• W2016751193 created "2016-06-24" @default.
• W2016751193 creator A5023597207 @default.
• W2016751193 creator A5024742955 @default.
• W2016751193 date "2013-11-01" @default.
• W2016751193 modified "2023-09-27" @default.
• W2016751193 title "Evaluation of the in vitro activity of fosfomycin tromethamine against Gram-negative bacterial strains recovered from community- and hospital-acquired urinary tract infections in Turkey" @default.
• W2016751193 cites W1964074354 @default.
• W2016751193 cites W1972323571 @default.
• W2016751193 cites W1991703638 @default.
• W2016751193 cites W1991862191 @default.
• W2016751193 cites W1993406511 @default.
• W2016751193 cites W2002116702 @default.
• W2016751193 cites W2010211973 @default.
• W2016751193 cites W2013230343 @default.
• W2016751193 cites W2017210944 @default.
• W2016751193 cites W2020421691 @default.
• W2016751193 cites W2064659537 @default.
• W2016751193 cites W2084385937 @default.
• W2016751193 cites W2086228598 @default.
• W2016751193 cites W2086752449 @default.
• W2016751193 cites W2095954292 @default.
• W2016751193 cites W2106489693 @default.
• W2016751193 cites W2115701715 @default.
• W2016751193 cites W2120866334 @default.
• W2016751193 cites W2122100919 @default.
• W2016751193 cites W2125348332 @default.
• W2016751193 cites W2127984455 @default.
• W2016751193 cites W2128480475 @default.
• W2016751193 cites W2129259344 @default.
• W2016751193 cites W2135346255 @default.
• W2016751193 cites W2141026906 @default.
• W2016751193 cites W2141328216 @default.
• W2016751193 cites W2142754694 @default.
• W2016751193 cites W2156566731 @default.
• W2016751193 cites W2159586727 @default.
• W2016751193 cites W2161779733 @default.
• W2016751193 doi "https://doi.org/10.1016/j.ijid.2013.04.005" @default.
• W2016751193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23742831" @default.
• W2016751193 hasPublicationYear "2013" @default.
• W2016751193 type Work @default.
• W2016751193 sameAs 2016751193 @default.
• W2016751193 citedByCount "47" @default.
• W2016751193 countsByYear W20167511932013 @default.
• W2016751193 countsByYear W20167511932014 @default.
• W2016751193 countsByYear W20167511932015 @default.
• W2016751193 countsByYear W20167511932016 @default.
• W2016751193 countsByYear W20167511932017 @default.
• W2016751193 countsByYear W20167511932018 @default.
• W2016751193 countsByYear W20167511932019 @default.
• W2016751193 countsByYear W20167511932020 @default.
• W2016751193 countsByYear W20167511932021 @default.
• W2016751193 countsByYear W20167511932022 @default.
• W2016751193 countsByYear W20167511932023 @default.
• W2016751193 crossrefType "journal-article" @default.
• W2016751193 hasAuthorship W2016751193A5023597207 @default.
• W2016751193 hasAuthorship W2016751193A5024742955 @default.
• W2016751193 hasBestOaLocation W20167511931 @default.
• W2016751193 hasConcept C104317684 @default.
• W2016751193 hasConcept C2775945818 @default.
• W2016751193 hasConcept C2776450100 @default.
• W2016751193 hasConcept C2777058267 @default.
• W2016751193 hasConcept C2778466173 @default.
• W2016751193 hasConcept C2778897966 @default.
• W2016751193 hasConcept C2778983983 @default.
• W2016751193 hasConcept C2779116282 @default.
• W2016751193 hasConcept C2779631663 @default.
• W2016751193 hasConcept C2780796207 @default.
• W2016751193 hasConcept C2781463711 @default.
• W2016751193 hasConcept C4937899 @default.
• W2016751193 hasConcept C501593827 @default.
• W2016751193 hasConcept C523546767 @default.
• W2016751193 hasConcept C54355233 @default.
• W2016751193 hasConcept C547475151 @default.
• W2016751193 hasConcept C55493867 @default.
• W2016751193 hasConcept C86803240 @default.
• W2016751193 hasConcept C89423630 @default.
• W2016751193 hasConcept C94665300 @default.
• W2016751193 hasConceptScore W2016751193C104317684 @default.
• W2016751193 hasConceptScore W2016751193C2775945818 @default.
• W2016751193 hasConceptScore W2016751193C2776450100 @default.
• W2016751193 hasConceptScore W2016751193C2777058267 @default.
• W2016751193 hasConceptScore W2016751193C2778466173 @default.
• W2016751193 hasConceptScore W2016751193C2778897966 @default.
• W2016751193 hasConceptScore W2016751193C2778983983 @default.
• W2016751193 hasConceptScore W2016751193C2779116282 @default.
• W2016751193 hasConceptScore W2016751193C2779631663 @default.
• W2016751193 hasConceptScore W2016751193C2780796207 @default.
• W2016751193 hasConceptScore W2016751193C2781463711 @default.
• W2016751193 hasConceptScore W2016751193C4937899 @default.
• W2016751193 hasConceptScore W2016751193C501593827 @default.
• W2016751193 hasConceptScore W2016751193C523546767 @default.
• W2016751193 hasConceptScore W2016751193C54355233 @default.
• W2016751193 hasConceptScore W2016751193C547475151 @default.
• W2016751193 hasConceptScore W2016751193C55493867 @default.
• W2016751193 hasConceptScore W2016751193C86803240 @default.
• W2016751193 hasConceptScore W2016751193C89423630 @default.
• W2016751193 hasConceptScore W2016751193C94665300 @default.

• next